Thursday , May 25 2017
Home / Tag Archives: Global Cardiovascular Outcomes Trial in Bempedoic Acid

Tag Archives: Global Cardiovascular Outcomes Trial in Bempedoic Acid

Esperion Therapeutics Cholesterol Drug Issue with FDA

Esperion Therapeutics Cholesterol Drug

Esperion Therapeutics Cholesterol Drug Esperion Therapeutics, Inc. is a public, American pharmaceutical company focused on the development of a first-in-class, orally available, small molecule designed to significantly lower elevated levels of LDL-C – with the reduced potential for muscle-related side effects associated with statin use. Company Overview Esperion is a ...

Read More »